#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebral amyloid angiopathy Ocular lymphoma Chronic myelomonocytic leukaemia Thalassaemia Nephropathy Sarcoidosis Intracranial calcification Loeys-Dietz syndrome Autoinflammation with infantile enterocolitis Langerhans' cell histiocytosis Neurodevelopmental disorder Chronic hepatitis B Lymphangiosarcoma Ovarian cancer stage III Neuropathy peripheral More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Diagnostics Encephalitis autoimmune – Diagnostics Haemophilia B with anti factor IX – Life with Disease Progressive supranuclear palsy Acquired haemophilia – Treatment Shprintzen-Goldberg syndrome – Trials in Disease Glycogen storage disease type I Marginal zone lymphoma Primary biliary cholangitis – Diagnostics Osteosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Letetresgene Autoleucel Copper (64Cu) Chloride Insulin Glargine ARI0008 Ruxotemitide Nortriptyline Hydrochloride Sodium Ascorbate Bisoprolol Terlipressin Acetate ALPROSTADIL Ciprofloxacin Acetylcysteine Amide IHMA-2121908-1 Bemarituzumab Vafidemstat Saxagliptin Methylphenidate Hydrochloride Mk-2060 Cefazolin Ritonavir More therapies…

    Learn about Your Condition

    Arterial stiffness Hyperkalaemia Mastocytosis Oxygen saturation Osteogenesis imperfecta Post cardiac arrest syndrome Pseudoxanthoma elasticum Primary biliary cholangitis Carotid artery stenosis Kearns-Sayre syndrome Burning mouth syndrome Hepatitis B Short-bowel syndrome Tetanus Overweight More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Critical illness

  • High-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Vitamin D deficiency
    • Critical illness
    Investigated Drugs:
    • Colecalciferol
    Austria Germany

  • Effect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • MAGNESIUM ACETATE TETRAHYDRATE
    • Magnesium Chloride Hexahydrate
    • MALIC ACID
    Germany

  • Study on Reducing Sodium Chloride and Glucose in Fluids for Critically Ill Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Magnesium Chloride Hexahydrate
    • Sodium Gluconate
    • Glucose Monohydrate
    Belgium

  • Study Comparing Isoflurane and Propofol for Sedation in Critically Ill Patients on Mechanical Ventilation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Isoflurane
    • Propofol
    Spain

  • Study on the Effects of Testosterone Gel on Physical Performance in Critically Ill Patients Requiring Long-Term Mechanical Ventilation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Testosterone
    • Placebo
    France

  • Study on Optimizing Ceftazidime-Avibactam Dosing for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Avibactam
    • Ceftazidime
    Belgium Spain Sweden
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!